Glutarol 10% w/v Cutaneous Solution
Product Information *
Company:
Dermal Laboratories (Ireland) LtdStatus:
No Recent UpdateActive Ingredients :
*Additional information is available upon request
Legal Category:
Supply through pharmacy only
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 17 December 2020
File name
GLUT-IPHA.SPC_1608206267.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Updated on 31 August 2018
File name
GLUT-IPHA.SPC.24.03.17.28.03.17_1535725539.pdf
Reasons for updating
- File format updated to PDF
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
File format updated to PDF
Updated on 28 March 2017
Reasons for updating
- New SPC for new product
Legal category:Supply through pharmacy only
Updated on 28 March 2017
Reasons for updating
- Change to section 6.3 - Shelf life
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
In section 10 (Date of revision of the text), the date has been changed from April 2015 to March 2017.
Updated on 13 April 2015
File name
PIL_8662_129.pdf
Reasons for updating
- New PIL for new product
Updated on 13 April 2015
Reasons for updating
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
- Improved electronic presentation
Legal category:Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via HPRA Pharmacovigilance, Earlsfort Terrace, IRL – Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; E-mail:medsafety@hpra.ie.
In section 10 Date of revision of the text, the date has changed to "April 2015"
Updated on 13 April 2015
Reasons for updating
- Change to date of revision
- Addition of information on reporting a side effect.
Updated on 24 July 2014
Reasons for updating
- Removal/change of distributor
- Change to date of revision
Updated on 04 December 2009
Reasons for updating
- Change due to user-testing of patient information
Updated on 29 August 2007
Reasons for updating
- Change to further information section
Updated on 11 September 2006
Reasons for updating
- Change of active ingredient
Updated on 18 August 2006
Reasons for updating
- Improved electronic presentation
Legal category:Supply through pharmacy only
Updated on 15 March 2006
Reasons for updating
- Change to section 6.3 - Shelf life
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Updated on 22 February 2006
Reasons for updating
- Change to section 1 - Name of medicinal product
- Change to section 6.4 - Special precautions for storage
- Change to section 6.5 - Nature and contents of container
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 9 - Date of renewal of authorisation
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Updated on 07 September 2004
Reasons for updating
- New PIL for medicines.ie
Updated on 12 June 2003
Reasons for updating
- New SPC for medicines.ie
Legal category:Supply through pharmacy only